More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Retinal Pharmaceutical Transactions Drive Ophthalmic Deals in First Quarter of 2024
Author: Chelsea Jones, MBA
Ophthalmic deals in Q1-2024 reached over $2.1 billion and involved 20 transactions. This compares with $2.0 billion from 17 transactions in Q1-2023 and $570 million from 12 transactions in Q4-2023. Public offerings totaled $612 million, while deals sourced by venture capital totaled $323 million. Strategic investor transactions totaled $378.3 million, and private placements totaled $798.3 million. Strategics are large multinational companies with significant revenue and cash that are able to ...
Purchasing one of the following products will open up access to this article's content, which is also available in each comprehensive report/subscription.
Recommended Products
This website uses cookies to ensure you get the best experience. By continuing to use our website, you consent to our use of cookies.